PT - JOURNAL ARTICLE AU - Knut Stavem AU - Waleed Ghanima AU - Magnus Kringstad Olsen AU - Hanne Margrethe Gilboe AU - Gunnar Einvik TI - Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study AID - 10.1136/thoraxjnl-2020-216377 DP - 2021 Apr 01 TA - Thorax PG - 405--407 VI - 76 IP - 4 4099 - http://thorax.bmj.com/content/76/4/405.short 4100 - http://thorax.bmj.com/content/76/4/405.full SO - Thorax2021 Apr 01; 76 AB - This study assessed symptoms and their determinants 1.5–6 months after symptom onset in non-hospitalised subjects with confirmed COVID-19 until 1 June 2020, in a geographically defined area. We invited 938 subjects; 451 (48%) responded. They reported less symptoms after 1.5–6 months than during COVID-19; median (IQR) 0 (0–2) versus 8 (6–11), respectively (p<0.001); 53% of women and 67% of men were symptom free, while 16% reported dyspnoea, 12% loss/disturbance of smell, and 10% loss/disturbance of taste. In multivariable analysis, having persistent symptoms was associated with the number of comorbidities and number of symptoms during the acute COVID-19 phase.